Company profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: breast health (38% of sales), diagnostics (26%) surgical (13%), medical aesthetics (10%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics, and the purchase of Cynosure establishes a footprint in the cosmetic laser market. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
25 June 2019 03:24:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB3 - 2019-06-25 04:24:25 - 2019-06-25 03:24:25 - 1000 - Website: OKAY